Key result
Recent data suggest that the safety window for deferring surgery after new-generation drug-eluting stent implantation could be shortened to less than 6 months.
New-generation drug-eluting stents may allow for safe surgical procedures less than 6 months post-PCI, challenging older paradigms that required a 12-month delay.
No takes yet. Share an insight, caveat, or question.
May support shorter surgery delays after new-generation DES; leaves open need for randomized confirmation before practice change.
Francesco Saia (2017) conducted a review in Patients with coronary drug-eluting stents needing surgery. Surgery after drug-eluting stent implantation was evaluated. Recent data suggest that the safety window for deferring surgery after new-generation drug-eluting stent implantation could be shortened to less than 6 months.